{"id":68071,"date":"2026-11-07T17:16:40","date_gmt":"2026-11-07T11:46:40","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=68071"},"modified":"2026-11-07T17:16:45","modified_gmt":"2026-11-07T11:46:45","slug":"interactive-cardiology-mcqs-30-cardiac-channelopathies","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/","title":{"rendered":"Interactive Cardiology MCQs 30: Cardiac Channelopathies"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<!-- Cardiology MCQs Part 30 (Full 25 Questions - Cardiac Channelopathies) - WordPress Safe Custom HTML Block -->\n<script src=\"https:\/\/cdn.tailwindcss.com?plugins=forms,typography,aspect-ratio\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: { preflight: false }\n  }\n<\/script>\n\n<div id=\"mcq30-quiz-wrapper\" class=\"font-sans bg-slate-950 text-slate-100 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-solid border-cyan-500\/20\" style=\"box-sizing: border-box;\">\n  \n  <!-- Background Accents -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-10 bg-[radial-gradient(ellipse_at_center,_var(--tw-gradient-stops))] from-cyan-500 via-blue-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-solid border-cyan-500\/25 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-cyan-500 via-blue-600 to-indigo-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-wider shadow-lg mb-3 animate-pulse\">\n      \u26a1 Advanced Cardiology Series &#8211; Part 30\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-cyan-300 via-blue-400 to-indigo-400 m-0\">\n      Interactive Cardiology MCQs #30\n    <\/h1>\n    <p class=\"text-sm md:text-lg text-slate-300 mt-2 max-w-2xl mx-auto font-medium\">\n      Post-Graduate Level Masterclass: Cardiac Channelopathies\n    <\/p>\n  <\/div>\n\n  <!-- Real-Time Floating Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/90 backdrop-blur-md border-2 border-solid border-cyan-500\/40 rounded-2xl p-4 mb-8 shadow-xl flex flex-wrap items-center justify-between gap-4\">\n    <div class=\"flex items-center gap-3\">\n      <div class=\"text-3xl\">\ud83e\uddec<\/div>\n      <div>\n        <div class=\"text-[10px] uppercase font-extrabold tracking-widest text-cyan-300\">Live Scoreboard<\/div>\n        <div class=\"text-lg md:text-2xl font-black text-blue-300 flex items-center gap-1\">\n          <span id=\"mcq30-correct-count\">0<\/span><span class=\"text-slate-500 text-sm md:text-lg\">\/ 25 Correct<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-2 bg-slate-950\/80 px-4 py-2 rounded-xl border border-solid border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-wider\">Progress:<\/span>\n      <div class=\"w-24 md:w-36 bg-slate-800 h-3 rounded-full overflow-hidden\">\n        <div id=\"mcq30-progress-bar\" class=\"bg-gradient-to-r from-cyan-500 to-blue-500 h-full w-0 transition-all duration-300 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-blue-300\"><span id=\"mcq30-answered-count\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-8 relative\">\n\n    <!-- Q1 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q1<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 12-year-old boy experiences a syncopal episode while swimming competitively. His resting ECG reveals a QTc of 490 ms. Which subtype of Congenital Long QT Syndrome (LQTS) is most classically triggered by physical exertion, particularly swimming?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"LQTS Type 1 (KCNQ1 mutation) is characterized by a high sensitivity to sympathetic stimulation. Arrhythmic events (Torsades de Pointes\/syncope) are most classically triggered by physical exertion, with swimming and diving being pathognomonic triggers. Reference: HRS\/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies.\">A) LQTS Type 1.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS Type 2 is classically triggered by sudden auditory stimuli (like an alarm clock or ringing phone) or emotional stress, not typically swimming.\">B) LQTS Type 2.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS Type 3 is characterized by events occurring during rest or sleep (bradycardia-dependent), rather than during exertion.\">C) LQTS Type 3.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS Type 7 (Andersen-Tawil Syndrome) presents with periodic paralysis, dysmorphic features, and ventricular arrhythmias, but swimming is not its classic trigger.\">D) LQTS Type 7.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q2<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with LQTS Type 3 has a gain-of-function mutation in the SCN5A gene. Based on this specific pathophysiological mechanism, which pharmacological agent is often used as a targeted, gene-specific therapy to shorten the QT interval in these patients?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Amiodarone is a Class III antiarrhythmic that significantly prolongs the QT interval and is contraindicated in congenital LQTS.\">A) Amiodarone.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Ivabradine lowers heart rate. Since LQTS 3 arrhythmias often occur at slow heart rates (bradycardia-dependent), ivabradine could worsen the condition.\">B) Ivabradine.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"LQTS 3 is caused by a gain-of-function mutation in the SCN5A gene, leading to a persistent late inward sodium current (I_Na) that delays repolarization. Mexiletine is a Class IB sodium channel blocker that effectively targets and suppresses this late sodium current, thereby shortening the QT interval specifically in LQTS 3 patients. Reference: AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias.\">C) Mexiletine.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sotalol has potent Class III (potassium channel blocking) effects, which prolong the QT interval and are dangerous in LQTS.\">D) Sotalol.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q3<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          What is the strict, diagnostic ECG criteria for a spontaneous Type 1 Brugada ECG pattern?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Saddleback ST elevation defines a Type 2 or Type 3 Brugada pattern, not the diagnostic Type 1 pattern.\">A) Saddleback-type ST-segment elevation of at least 1 mm in leads V1 and V2, followed by a positive T wave.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A Type 1 Brugada ECG pattern is diagnostic and is defined as a prominent coved ST-segment elevation measuring greater than or equal to 2 mm at the J-point, followed by a gradually descending ST segment and a negative, symmetric T wave in at least one right precordial lead (V1 or V2), positioned in the 2nd, 3rd, or 4th intercostal space. Reference: JACC State-of-the-Art Review on Brugada Syndrome.\">B) Coved-type ST-segment elevation greater than or equal to 2 mm in at least one right precordial lead (V1-V2), followed by a negative T wave.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Epsilon waves in V1-V3 are the diagnostic hallmark of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), not Brugada syndrome.\">C) The presence of an Epsilon wave at the end of the QRS complex in leads V1 through V3.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"J-point elevation with terminal QRS slurring in the inferior or lateral leads defines Early Repolarization Syndrome, not Brugada.\">D) J-point elevation greater than 2 mm with terminal QRS slurring strictly in the inferior leads (II, III, aVF).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q4<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 35-year-old male with a family history of sudden cardiac death undergoes a sodium channel blocker challenge test (using Ajmaline or Flecainide) to unmask a hidden condition. Which channelopathy is this test specifically designed to provoke?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Brugada Syndrome is primarily driven by a loss-of-function in the cardiac sodium channel (Nav1.5). Administering a potent sodium channel blocker (like Ajmaline, Flecainide, or Procainamide) further reduces the available sodium current, exaggerating the transmural voltage gradient in the right ventricle and actively unmasking a concealed Type 1 Brugada ECG pattern. Reference: ESC Guidelines for the Management of Patients with Ventricular Arrhythmias.\">A) Brugada Syndrome.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is unmasked by exercise testing or epinephrine infusion, not sodium channel blockers.\">B) Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS 1 is diagnosed via resting ECG and exercise testing. Flecainide is not used to provoke LQTS.\">C) Congenital Long QT Syndrome Type 1.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Short QT Syndrome is diagnosed on resting ECG by a QTc consistently less than 340 ms; it is not provoked by sodium channel blockade.\">D) Short QT Syndrome.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q5<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In a structurally normal heart, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a highly lethal genetic arrhythmia. Which genetic mutation accounts for the majority of autosomal dominant CPVT cases?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"SCN5A mutations cause Brugada syndrome, LQTS 3, and progressive cardiac conduction disease, not CPVT.\">A) SCN5A.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"KCNQ1 is the most common mutation responsible for Long QT Syndrome Type 1.\">B) KCNQ1.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"CPVT is a disease of abnormal intracellular calcium handling. Mutations in the RyR2 gene (Ryanodine Receptor 2), which regulates calcium release from the sarcoplasmic reticulum, account for approximately 60 percent of cases and are inherited in an autosomal dominant pattern. CASQ2 (Calsequestrin 2) mutations cause a rarer, autosomal recessive form of CPVT. Reference: HRS\/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies.\">C) RyR2 (Ryanodine Receptor 2).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"PKP2 (Plakophilin-2) is a desmosomal gene mutation responsible for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).\">D) PKP2.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q6<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During an exercise treadmill test, a 14-year-old patient develops frequent premature ventricular complexes (PVCs) that progressively organize into a specific, highly characteristic ventricular tachycardia pattern. What is the hallmark arrhythmia of CPVT?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Torsades de Pointes is the hallmark arrhythmia of Long QT Syndrome, typically characterized by a twisting QRS morphology around the isoelectric line.\">A) Torsades de Pointes.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The pathognomonic arrhythmia for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) during adrenergic stress (exercise or emotion) is Bidirectional Ventricular Tachycardia. The QRS axis alternates 180 degrees from beat to beat (one beat positive, the next negative) on the ECG, reflecting alternating ectopic foci in the right and left ventricles due to calcium overload. Reference: ACC\/AHA\/HRS Ventricular Arrhythmia Guidelines.\">B) Bidirectional Ventricular Tachycardia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Monomorphic VT with an LBBB morphology and inferior axis typically originates from the RV outflow tract (RVOT VT), which is generally benign and unrelated to CPVT.\">C) Monomorphic Ventricular Tachycardia with an LBBB morphology and inferior axis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fascicular VT is usually a verapamil-sensitive monomorphic VT in young adults, not the polymorphic\/bidirectional pattern of CPVT.\">D) Idiopathic Left Ventricular Fascicular Tachycardia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q7<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Short QT Syndrome (SQTS) is a rare, highly lethal channelopathy characterized by an abnormally short repolarization time. According to current guidelines, at what QTc threshold should a diagnosis of SQTS be strongly considered in an asymptomatic patient?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A QTc of 380 ms is on the lower end of normal but does not meet the diagnostic criteria for Short QT Syndrome.\">A) A QTc consistently less than 380 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Short QT Syndrome is a rare genetic disorder characterized by an extremely short QT interval. Current ESC and HRS guidelines state that SQTS should be diagnosed in the presence of a QTc less than or equal to 340 ms. It can also be considered at a QTc less than 360 ms if there is a pathogenic mutation, family history of SQTS, or survival from a sudden cardiac arrest. Reference: ESC Guidelines for the Management of Patients with Ventricular Arrhythmias.\">B) A QTc consistently less than or equal to 340 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While a QTc less than 320 ms is definitively pathological, the official diagnostic threshold begins at 340 ms.\">C) A QTc consistently less than 320 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A QTc of 400 ms is perfectly normal for most adults.\">D) A QTc consistently less than 400 ms.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q8<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Andersen-Tawil Syndrome (Long QT Syndrome Type 7) is characterized by a specific clinical triad resulting from a loss-of-function mutation in the KCNJ2 gene. What three features constitute this triad?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sensorineural deafness combined with severe LQTS defines Jervell and Lange-Nielsen syndrome, not Andersen-Tawil.\">A) Sensorineural deafness, prolonged QTc interval, and iron deficiency anemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Andersen-Tawil Syndrome (LQTS 7) is a rare potassium channelopathy (KCNJ2 mutation). It is uniquely characterized by a clinical triad: 1) Potassium-sensitive periodic paralysis (muscle weakness), 2) Ventricular arrhythmias (frequent PVCs, bidirectional VT, and prominent U waves rather than severe QT prolongation), and 3) Dysmorphic facial and skeletal features (micrognathia, low-set ears, syndactyly, scoliosis). Reference: HRS\/EHRA Expert Consensus Statement on Channelopathies.\">B) Periodic muscle paralysis, ventricular arrhythmias (with prominent U waves), and dysmorphic skeletal\/facial features.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Syndactyly, autism spectrum disorder, and extreme QT prolongation define Timothy Syndrome (LQTS 8).\">C) Syndactyly, autism spectrum disorder, and extreme QT prolongation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Bilateral cataracts and hypertrophic cardiomyopathy do not define Andersen-Tawil syndrome.\">D) Bilateral cataracts, hypertrophic cardiomyopathy, and prolonged QTc interval.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q9<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Timothy Syndrome (Long QT Syndrome Type 8) is a highly lethal, multi-system channelopathy caused by a gain-of-function mutation in CACNA1C. Which ion channel is directly affected by this mutation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The rapid delayed rectifier potassium channel (I_Kr) is affected in LQTS Type 2 (KCNH2\/hERG).\">A) The rapid delayed rectifier potassium channel (I_Kr).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Timothy Syndrome (LQTS 8) is caused by a missense mutation in the CACNA1C gene, which encodes the alpha-1C subunit of the L-type calcium channel (Cav1.2). This gain-of-function mutation prevents the channel from inactivating properly, leading to calcium overload, extreme QT prolongation (often greater than 600 ms), syndactyly, autism, and severe structural congenital heart defects. Reference: Genetics of Cardiac Arrhythmias.\">B) The L-type calcium channel (Cav1.2).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The cardiac sodium channel (Nav1.5) is affected in LQTS Type 3 and Brugada syndrome (SCN5A).\">C) The cardiac sodium channel (Nav1.5).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The ryanodine receptor is an intracellular calcium release channel on the sarcoplasmic reticulum, mutated in CPVT, not Timothy syndrome.\">D) The sarcoplasmic reticulum Ryanodine receptor (RyR2).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q10<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Jervell and Lange-Nielsen Syndrome is a rare, severe form of Long QT Syndrome associated with profound bilateral sensorineural deafness. How is this specific syndrome genetically inherited?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Romano-Ward syndrome is the autosomal dominant form of LQTS (normal hearing), which accounts for the vast majority of LQTS cases.\">A) Autosomal dominant inheritance of a single KCNQ1 mutation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Jervell and Lange-Nielsen Syndrome is an autosomal recessive disorder. It requires a patient to inherit two mutant alleles (homozygous or compound heterozygous mutations) in either the KCNQ1 or KCNE1 genes. These genes govern potassium channels in both the heart and the inner ear (stria vascularis). Because both alleles are mutated, potassium endolymph secretion in the ear fails (causing deafness), and cardiac repolarization is severely compromised (causing extreme LQTS). Reference: Heart Rhythm Society Expert Consensus.\">B) Autosomal recessive inheritance (homozygous or compound heterozygous mutations in KCNQ1 or KCNE1).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"X-linked dominant inheritance is seen in disorders like Danon disease, but JLNS is autosomal recessive.\">C) X-linked dominant inheritance of the KCNH2 gene.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Mitochondrial inheritance (maternal transmission) causes diseases like Kearns-Sayre syndrome (which causes AV block), not JLNS.\">D) Mitochondrial inheritance passed exclusively from the mother.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q11<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Acquired Long QT Syndrome is far more common than congenital forms and is frequently driven by prescription medications. Virtually all drugs that cause acquired LQTS do so by blocking which specific cardiac ion current?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The vast majority of drugs that cause acquired Long QT Syndrome (including macrolide antibiotics, haloperidol, methadone, and Class III antiarrhythmics) do so by blocking the rapid delayed rectifier potassium current (I_Kr). This current is conducted by the hERG (KCNH2) channel. Because the hERG channel has a uniquely large inner cavity, it is highly susceptible to becoming physically plugged by a wide variety of molecular structures. Reference: AHA Scientific Statement on Prevention of Torsade de Pointes.\">A) The rapid delayed rectifier potassium current (I_Kr) via the hERG channel.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The slow delayed rectifier potassium current (I_Ks) is implicated in congenital LQTS 1, but is rarely the primary target for drug-induced acquired LQTS.\">B) The slow delayed rectifier potassium current (I_Ks) via the KCNQ1 channel.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Blocking the fast inward sodium current (I_Na) shortens the QT or widens the QRS (Brugada pattern), it does not cause Torsades de Pointes.\">C) The fast inward sodium current (I_Na) via the SCN5A channel.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Blocking L-type calcium channels (with drugs like verapamil) typically shortens the QT interval.\">D) The inward L-type calcium current (I_CaL) via the Cav1.2 channel.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q12<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) who continue to experience breakthrough arrhythmias despite maximum tolerated beta-blocker therapy, what is the guideline-directed next step in pharmacological management?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Amiodarone is not a preferred first-line or add-on therapy for CPVT; it is inferior to targeted sodium channel blockade for this specific calcium-handling defect.\">A) Add Amiodarone.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"For CPVT patients experiencing breakthrough arrhythmias on non-selective beta-blockers (like nadolol), the addition of Flecainide is the guideline-directed next step. Flecainide not only blocks sodium channels but has a direct inhibitory effect on the Ryanodine receptor (RyR2), dramatically reducing spontaneous calcium release and preventing bidirectional VT. Reference: ACC\/AHA\/HRS Ventricular Arrhythmia Guidelines.\">B) Add Flecainide.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Digoxin increases intracellular calcium, which would catastrophically worsen CPVT and trigger lethal arrhythmias.\">C) Add Digoxin.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Verapamil is sometimes used for fascicular VT, but is not the standard highly-effective add-on for CPVT compared to flecainide.\">D) Add Verapamil.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q13<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          At the cellular level, what is the specific electrophysiological mechanism responsible for triggering Torsades de Pointes in Long QT Syndrome?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Delayed afterdepolarizations (DADs) occur during phase 4 resting potential due to calcium overload and are the mechanism for CPVT and digitalis toxicity, not LQTS.\">A) Delayed Afterdepolarizations (DADs) occurring in Phase 4 of the action potential.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Torsades de Pointes in LQTS is triggered by Early Afterdepolarizations (EADs). Because the repolarization phase (Phase 2 or Phase 3) is abnormally prolonged, L-type calcium channels have time to recover from inactivation and spontaneously reopen before the cell has fully repolarized. This secondary inward flow of positive calcium ions creates an EAD, which can trigger a premature action potential and initiate the twisting ventricular tachycardia known as Torsades. Reference: Electrophysiological Mechanisms of Ventricular Arrhythmias.\">B) Early Afterdepolarizations (EADs) occurring in Phase 2 or Phase 3 of the action potential.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anatomical macro-reentry around a fixed scar is the mechanism for monomorphic VT in ischemic cardiomyopathy, not Torsades de Pointes.\">C) Anatomical macro-reentry around a fixed fibrotic scar in the left ventricle.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Enhanced normal automaticity of the SA node causes sinus tachycardia, not polymorphic ventricular tachycardia.\">D) Enhanced normal automaticity of the sinoatrial node.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q14<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 45-year-old male with a known Type 1 Brugada ECG pattern presents to the ER with multiple shocks from his ICD due to a &#8216;Brugada storm&#8217; (incessant ventricular fibrillation). Which intravenous medication is the most effective pharmacological treatment to acutely suppress electrical storms in Brugada Syndrome?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Amiodarone is generally ineffective for Brugada storms and may even worsen the transmural dispersion of repolarization.\">A) Amiodarone.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Isoproterenol (a potent non-selective beta-agonist) is the acute drug of choice for Brugada electrical storm. By increasing heart rate and boosting the inward calcium current (I_CaL), it restores the electrical balance in the epicardium and abolishes the arrhythmogenic transmural voltage gradient. Alternatively, oral Quinidine (which blocks the outward I_to current) is highly effective for chronic suppression of Brugada storms. Reference: JACC State-of-the-Art Review on Brugada Syndrome.\">B) Isoproterenol.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Flecainide is a sodium channel blocker; it actively provokes Brugada syndrome and would fatally exacerbate a Brugada storm.\">C) Flecainide.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Magnesium sulfate is the acute treatment for Torsades de Pointes (Long QT), not for Brugada VF storms.\">D) Magnesium Sulfate.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q15<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Early Repolarization Syndrome (ERS) is recognized as a potential cause of idiopathic ventricular fibrillation. What specific ECG morphology in the inferior or lateral leads carries the highest risk for arrhythmic events in ERS?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Concave, upward-sloping ST elevation is typically a benign variant commonly seen in healthy young athletes.\">A) Rapidly rapidly ascending, concave ST-segment elevation without terminal QRS slurring.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"While early repolarization is a common, benign finding in many healthy individuals, Early Repolarization Syndrome (ERS) is malignant. The highest risk of idiopathic ventricular fibrillation in ERS is associated with a distinct J-point elevation (greater than or equal to 1 mm) accompanied by notching or slurring of the terminal QRS complex, followed by a horizontal or descending (down-sloping) ST segment, predominantly located in the inferior or inferolateral leads. Reference: HRS\/EHRA Expert Consensus Statement on Early Repolarization.\">B) J-point elevation with prominent terminal QRS notching or slurring, followed by a horizontal or descending ST segment.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Coved ST elevation defines Brugada syndrome, which affects the right precordial leads (V1-V2), not the inferior\/lateral leads of ERS.\">C) A coved ST segment leading into a deep, symmetric negative T wave.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"An epsilon wave is the hallmark of ARVC, entirely unrelated to early repolarization.\">D) A discrete epsilon wave immediately following the QRS complex.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q16<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient\u2019s baseline resting ECG is completely normal, with no QT prolongation and no resting arrhythmias. However, during maximal treadmill exertion, he collapses into ventricular fibrillation. Which channelopathy classically features a completely normal resting ECG but high lethality during adrenergic stress?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS 1 is triggered by exertion, but the resting ECG typically shows a prolonged QT interval (often a broad T wave).\">A) Long QT Syndrome Type 1.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada syndrome presents with a resting coved ST elevation in V1-V2 and arrhythmias typically occur at rest or during sleep, not exertion.\">B) Brugada Syndrome.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"One of the most insidious features of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is that the resting 12-lead ECG is classically completely normal (no prolonged QT, no ST changes). The lethal arrhythmias (bidirectional VT or VF) are only unmasked by sudden adrenergic surges, such as intense exercise or emotional shock. Reference: AHA\/ACC\/HRS Ventricular Arrhythmia Guidelines.\">C) Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Short QT Syndrome presents with an obvious, constantly short QTc on the resting ECG.\">D) Short QT Syndrome.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q17<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In calculating the Schwartz Score for the clinical diagnosis of Long QT Syndrome, which specific QTc measurement yields the maximum possible points (3 points) in the scoring system?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A QTc of 450 ms gives 1 point in males, but does not yield the maximum score.\">A) QTc greater than or equal to 450 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A QTc between 460 and 479 ms yields 2 points in the Schwartz scoring system.\">B) QTc greater than or equal to 460 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The Schwartz Score is a clinical diagnostic tool for LQTS. The criteria heavily weight extreme repolarization delays. A calculated QTc of greater than or equal to 480 ms yields the maximum 3 points. A total score of greater than or equal to 3.5 points signifies a high probability of congenital Long QT Syndrome. Reference: HRS\/EHRA Expert Consensus Statement on Channelopathies.\">C) QTc greater than or equal to 480 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While 500 ms is extremely dangerous, the ceiling threshold for the maximum 3 points in the Schwartz criteria is set at 480 ms.\">D) QTc greater than or equal to 500 ms.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q18<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Certain clinical scenarios and physiological stressors can mimic a Brugada Type 1 ECG pattern in a patient without the actual genetic syndrome. Which severe electrolyte abnormality is the most famous &#8216;Brugada phenocopy&#8217;?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypokalemia typically causes prominent U waves and QT prolongation (mimicking LQTS), not Brugada.\">A) Severe Hypokalemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Severe Hyperkalemia is a well-documented 'Brugada phenocopy'. Extremely high potassium levels alter the resting membrane potential and drastically slow phase 0 depolarization. This can produce an ECG pattern featuring widened QRS complexes and coved ST elevations in V1-V2 that are virtually indistinguishable from true genetic Brugada syndrome, but which resolve completely upon normalization of potassium levels. Reference: International Registry on Brugada Phenocopies.\">B) Severe Hyperkalemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypocalcemia prolongs the ST segment resulting in a long QT interval, it does not create a coved ST elevation.\">C) Severe Hypocalcemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypercalcemia shortens the QT interval and can cause Osborn (J) waves, but is not a classic mimic of the Brugada pattern.\">D) Severe Hypercalcemia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q19<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Idiopathic Ventricular Fibrillation (IVF) is diagnosed when a patient suffers VF without any identifiable structural or electrocardiographic abnormality. Research has shown these storms are often triggered by very early, short-coupled PVCs originating from which specific anatomical structure?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The SA node triggers atrial depolarization, not short-coupled ventricular PVCs causing VF.\">A) The Sinoatrial (SA) Node.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The Right Ventricular Outflow Tract (RVOT) frequently produces benign, wide-coupled PVCs (LBBB, inferior axis) but is rarely the source of short-coupled, highly malignant IVF triggers.\">B) The Right Ventricular Outflow Tract (RVOT) free wall.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A significant subset of Idiopathic Ventricular Fibrillation (IVF) is triggered by 'short-coupled PVCs' (the R-on-T phenomenon). Electrophysiological studies have demonstrated that these malignant triggering PVCs frequently originate from the Purkinje fiber network (often the left or right Purkinje arborization). In patients with recurrent IVF storms, catheter ablation targeting these specific Purkinje triggers can be highly effective. Reference: ACC\/AHA\/HRS Ventricular Arrhythmia Guidelines.\">C) The distal Purkinje fiber network.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The coronary sinus musculature can cause atrial tachycardias or bypass tract conduction, not short-coupled IVF triggers.\">D) The musculature of the Coronary Sinus.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q20<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Different genetic subtypes of Long QT Syndrome produce distinct T wave morphologies on the ECG. Which of the following accurately matches the LQTS subtype with its classic T wave appearance?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Genotype-phenotype correlations in LQTS note distinct ECG patterns. LQTS Type 1 typically presents with a broad-based, early-onset T wave. LQTS Type 2 characteristically shows a low-amplitude, notched or 'bifid' T wave. LQTS Type 3 presents with a prolonged, flat isoelectric ST segment followed by a late-peaking T wave. Reference: HRS\/EHRA Expert Consensus Statement on Channelopathies.\">A) LQTS Type 1 presents with a broad-based, early-onset T wave.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A late-peaking T wave following a long, flat ST segment is the classic hallmark of LQTS Type 3, not Type 2.\">B) LQTS Type 2 presents with a prolonged isoelectric ST segment and a late-peaking T wave.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Notched or bifid T waves are the classic hallmark of LQTS Type 2, not Type 3.\">C) LQTS Type 3 presents with a low-amplitude, notched (bifid) T wave.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Short, peaked T waves are a sign of hyperkalemia or Short QT syndrome, not any form of Long QT syndrome.\">D) LQTS Type 1 presents with extremely tall, narrow, and peaked T waves.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q21<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Pregnancy and the postpartum period carry varying risks for women with congenital Long QT Syndrome depending on their genotype. Which genotype is associated with a massively increased risk of cardiac events during the 9-month postpartum period?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS 1 patients are at highest risk during physical exertion (like swimming) and actually see a relative decrease in risk during the postpartum period.\">A) LQTS Type 1.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Women with LQTS Type 2 (KCNH2 mutation) are at extremely high risk for life-threatening arrhythmic events during the postpartum period (the 9 months following delivery). This heightened risk is primarily driven by postpartum sleep deprivation and sudden auditory startles (e.g., a baby crying or an alarm clock in the middle of the night), which are the hallmark triggers for LQTS 2. Reference: ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy.\">B) LQTS Type 2.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LQTS 3 events happen at rest\/sleep, but the specific massive spike in postpartum risk is epidemiologically linked to LQTS 2.\">C) LQTS Type 3.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Andersen-Tawil syndrome does not have a specific, documented surge in postpartum lethality compared to LQTS 2.\">D) LQTS Type 7.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q22<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with Short QT Syndrome, the refractory period of both the ventricles and the atria is significantly shortened. As a direct consequence, what is the most common clinical arrhythmia presentation in these patients, aside from sudden death?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AVNRT relies on dual AV nodal pathways, which are congenital anatomical variants, not primarily driven by the shortened repolarization of SQTS.\">A) Atrioventricular Nodal Reentrant Tachycardia (AVNRT).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Because Short QT Syndrome involves a profound shortening of the action potential and refractory period across the entire heart, both the ventricles and the atria are affected. Due to the extremely short atrial refractory period, the most common clinical presentation\u2014often seen even in young children or teenagers with SQTS\u2014is the development of highly symptomatic, early-onset Atrial Fibrillation. Reference: ACC\/AHA\/HRS Ventricular Arrhythmia Guidelines.\">B) Early-onset Atrial Fibrillation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sinus node dysfunction is associated with HCN4 mutations or severe aging, not the shortened refractory periods of SQTS.\">C) Severe Sinus Bradycardia and chronotropic incompetence.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fascicular VT is an idiopathic VT usually unrelated to generalized repolarization defects.\">D) Idiopathic Left Ventricular Fascicular Tachycardia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q23<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Brugada Syndrome is heavily influenced by autonomic tone. Which physiologic state or condition famously exacerbates the Brugada Type 1 ECG pattern and dramatically increases the risk of ventricular fibrillation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Intense physical exercise triggers arrhythmias in CPVT and LQTS 1, but actually suppresses the Brugada pattern by increasing sympathetic tone.\">A) Intense physical exertion and tachycardia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Brugada Syndrome arrhythmogenesis is highly dependent on high vagal (parasympathetic) tone and temperature variations. The risk of ventricular fibrillation is massively increased during rest, sleep (especially REM sleep), after heavy meals, and during episodes of Fever. Fever is a particularly potent trigger that can unmask a Type 1 Brugada pattern in previously asymptomatic individuals, and aggressive antipyretic therapy is mandatory. Reference: JACC State-of-the-Art Review on Brugada Syndrome.\">B) States of high vagal tone (sleep\/rest) and febrile illness (fever).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sudden auditory stimuli (alarm clocks) are the classic trigger for LQTS Type 2, not Brugada syndrome.\">C) Sudden auditory stimuli such as an alarm clock ringing.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypothermia causes J waves (Osborn waves), but it is hyperthermia (fever) that specifically alters the mutant Nav1.5 kinetics to provoke Brugada.\">D) Severe hypothermia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q24<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In evaluating a patient with recurrent syncope and a borderline prolonged QTc interval, you order an epinephrine challenge test. During the infusion, the QTc paradoxically lengthens by more than 30 ms. This abnormal response is highly specific for diagnosing which condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"In normal individuals, epinephrine shortens the action potential, thereby appropriately shortening the QT interval as heart rate increases.\">A) A normal, healthy physiological response.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The Epinephrine Challenge test is used to unmask concealed Long QT Syndrome, specifically LQTS Type 1. In a normal heart, beta-adrenergic stimulation by epinephrine accelerates repolarization, causing the QTc to shorten. In LQTS 1 (where the slow delayed rectifier potassium current I_Ks is defective), the heart fails to accelerate repolarization to match the faster heart rate. Thus, the QTc paradoxically lengthens (by greater than or equal to 30 ms). Reference: HRS\/EHRA Expert Consensus on Genetic Testing.\">B) Long QT Syndrome Type 1.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"CPVT is diagnosed on an epinephrine or exercise test by the provocation of bidirectional VT, not by paradoxical QT lengthening.\">C) Catecholaminergic Polymorphic Ventricular Tachycardia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada is provoked by sodium channel blockers (ajmaline\/flecainide), whereas epinephrine (a beta-agonist) actually suppresses the Brugada pattern.\">D) Brugada Syndrome.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-cyan-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-cyan-500\/30\">Q25<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the HRS\/EHRA\/APHRS Expert Consensus, asymptomatic patients with an incidentally discovered Type 1 Brugada ECG pattern who have NO family history of sudden cardiac death and NO history of syncope should be managed how?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Primary prevention ICDs are reserved for Brugada patients with a history of syncope, aborted sudden death, or highly concerning features, not fully asymptomatic incidental cases.\">A) Immediate implantation of a dual-chamber Implantable Cardioverter-Defibrillator (ICD).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Lifelong oral quinidine is used to suppress electrical storms in symptomatic patients, but is not prophylactically initiated in asymptomatic individuals.\">B) Initiation of lifelong oral Quinidine therapy.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"For strictly asymptomatic patients with a spontaneous or provoked Type 1 Brugada pattern and no high-risk family history, the risk of sudden cardiac death is remarkably low (less than 1 percent per year). Current guidelines recommend against primary ICD implantation or drug therapy. Instead, management consists of conservative lifestyle measures: strict avoidance of Brugada-provoking drugs, aggressive treatment of fevers with antipyretics, and avoidance of excessive alcohol and large carbohydrate-rich meals. Reference: ACC\/AHA\/HRS Ventricular Arrhythmia Guidelines.\">C) Conservative management focusing strictly on avoidance of triggering drugs, prompt treatment of fevers, and clinical observation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Ablation of the RVOT epicardium is an emerging therapy for highly symptomatic patients with recurrent VF storms, not asymptomatic incidental findings.\">D) Prophylactic epicardial catheter ablation of the right ventricular outflow tract (RVOT).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  let mcq30Correct = 0;\n  let mcq30Answered = 0;\n  const mcq30Total = 25;\n\n  document.querySelectorAll('#mcq30-quiz-wrapper .quiz-card').forEach(card => {\n    const buttons = card.querySelectorAll('.opt-btn');\n    buttons.forEach(btn => {\n      btn.addEventListener('click', function() {\n        if (card.getAttribute('data-answered') === 'true') return;\n        card.setAttribute('data-answered', 'true');\n        mcq30Answered++;\n\n        document.getElementById('mcq30-answered-count').innerText = mcq30Answered;\n        const pct = (mcq30Answered \/ mcq30Total) * 100;\n        document.getElementById('mcq30-progress-bar').style.width = pct + '%';\n\n        buttons.forEach(b => {\n          b.disabled = true;\n          b.classList.remove('hover:bg-slate-900', 'cursor-pointer');\n          b.classList.add('opacity-50', 'cursor-not-allowed');\n        });\n\n        const isCorrect = this.getAttribute('data-correct') === 'true';\n        const explanation = this.getAttribute('data-explanation');\n\n        if (isCorrect) {\n          mcq30Correct++;\n          document.getElementById('mcq30-correct-count').innerText = mcq30Correct;\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-teal-950\/80', 'border-teal-500', 'text-teal-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10004; CORRECT!<\/span>';\n        } else {\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-cyan-950\/80', 'border-blue-500', 'text-cyan-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10006; INCORRECT<\/span>';\n\n          buttons.forEach(b => {\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n              b.classList.add('bg-teal-950\/40', 'border-teal-500\/55', 'text-teal-200', 'opacity-100', 'border-2');\n              b.innerHTML += ' <span class=\"font-bold\">&#10004; (Correct)<\/span>';\n            }\n          });\n        }\n\n        const feedback = card.querySelector('.feedback-box');\n        feedback.innerHTML = `\n          <div class=\"font-extrabold uppercase tracking-widest text-xs mb-2 ${isCorrect ? 'text-teal-400' : 'text-cyan-400'}\">\n            ${isCorrect ? 'Clinical Explanation & Reference' : 'Explanation, Correct Answer & Reference'}\n          <\/div>\n          <p class=\"m-0\">${explanation}<\/p>\n        `;\n        feedback.classList.remove('hidden');\n        feedback.classList.add('block', isCorrect ? 'bg-teal-950\/45' : 'bg-cyan-950\/20', 'border-2', 'border-solid', isCorrect ? 'border-teal-500\/30' : 'border-blue-500\/30', 'text-slate-200', 'mt-4');\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>\u26a1 Advanced Cardiology Series &#8211; Part 30 Interactive Cardiology MCQs #30 Post-Graduate Level Masterclass: Cardiac Channelopathies \ud83e\uddec Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 A 12-year-old boy experiences a syncopal episode while swimming competitively. His resting ECG reveals a QTc of 490 ms. Which subtype of Congenital Long QT Syndrome (LQTS) is most classically [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":68072,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","nfd_image_url":"","nfd_onboarding_generated":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-68071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Interactive Cardiology MCQs 30: Cardiac Channelopathies - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Interactive Cardiology MCQs 30: Cardiac Channelopathies - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"\u26a1 Advanced Cardiology Series &#8211; Part 30 Interactive Cardiology MCQs #30 Post-Graduate Level Masterclass: Cardiac Channelopathies \ud83e\uddec Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 A 12-year-old boy experiences a syncopal episode while swimming competitively. His resting ECG reveals a QTc of 490 ms. Which subtype of Congenital Long QT Syndrome (LQTS) is most classically [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-07T11:46:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-07T11:46:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/11\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Interactive Cardiology MCQs 30: Cardiac Channelopathies\",\"datePublished\":\"2026-11-07T11:46:40+00:00\",\"dateModified\":\"2026-11-07T11:46:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/\"},\"wordCount\":1587,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/\",\"name\":\"Interactive Cardiology MCQs 30: Cardiac Channelopathies - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg\",\"datePublished\":\"2026-11-07T11:46:40+00:00\",\"dateModified\":\"2026-11-07T11:46:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg\",\"width\":1208,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/interactive-cardiology-mcqs-30-cardiac-channelopathies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Interactive Cardiology MCQs 30: Cardiac Channelopathies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Interactive Cardiology MCQs 30: Cardiac Channelopathies - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/","og_locale":"en_US","og_type":"article","og_title":"Interactive Cardiology MCQs 30: Cardiac Channelopathies - All About Cardiovascular System and Disorders","og_description":"\u26a1 Advanced Cardiology Series &#8211; Part 30 Interactive Cardiology MCQs #30 Post-Graduate Level Masterclass: Cardiac Channelopathies \ud83e\uddec Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 A 12-year-old boy experiences a syncopal episode while swimming competitively. His resting ECG reveals a QTc of 490 ms. Which subtype of Congenital Long QT Syndrome (LQTS) is most classically [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-11-07T11:46:40+00:00","article_modified_time":"2026-11-07T11:46:45+00:00","og_image":[{"width":1208,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/11\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Interactive Cardiology MCQs 30: Cardiac Channelopathies","datePublished":"2026-11-07T11:46:40+00:00","dateModified":"2026-11-07T11:46:45+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/"},"wordCount":1587,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/11\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/","url":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/","name":"Interactive Cardiology MCQs 30: Cardiac Channelopathies - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/11\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg","datePublished":"2026-11-07T11:46:40+00:00","dateModified":"2026-11-07T11:46:45+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/11\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/11\/Interactive-Cardiology-MCQs-30-Cardiac-Channelopathies.jpg","width":1208,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/interactive-cardiology-mcqs-30-cardiac-channelopathies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Interactive Cardiology MCQs 30: Cardiac Channelopathies"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=68071"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68071\/revisions"}],"predecessor-version":[{"id":68073,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68071\/revisions\/68073"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/68072"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=68071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=68071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=68071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}